vs
Forian Inc.（FORA）与Lakeside Holding Ltd（LSH）财务数据对比。点击上方公司名可切换其他公司
Forian Inc.的季度营收约是Lakeside Holding Ltd的1.1倍（$8.0M vs $7.0M），Lakeside Holding Ltd净利率更高（-22.6% vs -22.9%，领先0.3%），Lakeside Holding Ltd同比增速更快（95.0% vs 37.0%）
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商，提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务，客户覆盖生物制药企业、医疗机构及生命科学领域相关机构，助力提升诊疗效率、推动医学研究进展。
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
FORA vs LSH — 直观对比
营收规模更大
FORA
是对方的1.1倍
$7.0M
营收增速更快
LSH
高出58.0%
37.0%
净利率更高
LSH
高出0.3%
-22.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $7.0M |
| 净利润 | $-1.8M | $-1.6M |
| 毛利率 | 49.2% | 27.2% |
| 营业利润率 | -24.4% | -21.3% |
| 净利率 | -22.9% | -22.6% |
| 营收同比 | 37.0% | 95.0% |
| 净利润同比 | -1012.2% | 18.7% |
| 每股收益（稀释后） | $-0.06 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORALSH
| Q4 25 | $8.0M | $7.0M | ||
| Q3 25 | $7.8M | $6.1M | ||
| Q2 25 | $7.5M | $6.3M | ||
| Q1 25 | $7.1M | $3.8M | ||
| Q4 24 | $5.8M | $3.6M | ||
| Q3 24 | $4.7M | $4.1M | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | $4.9M | — |
净利润FORALSH
| Q4 25 | $-1.8M | $-1.6M | ||
| Q3 25 | $-151.2K | $-1.4M | ||
| Q2 25 | $224.8K | $-893.1K | ||
| Q1 25 | $-1.1M | $-1.1M | ||
| Q4 24 | $199.7K | $-1.9M | ||
| Q3 24 | $-204.9K | $-1.3M | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-1.2M | — |
毛利率FORALSH
| Q4 25 | 49.2% | 27.2% | ||
| Q3 25 | 51.6% | 18.2% | ||
| Q2 25 | 56.8% | 26.7% | ||
| Q1 25 | 55.6% | 18.8% | ||
| Q4 24 | 58.3% | -1.2% | ||
| Q3 24 | 70.1% | 12.8% | ||
| Q2 24 | 62.2% | — | ||
| Q1 24 | 65.1% | — |
营业利润率FORALSH
| Q4 25 | -24.4% | -21.3% | ||
| Q3 25 | -6.1% | -20.8% | ||
| Q2 25 | 0.6% | -8.9% | ||
| Q1 25 | -19.8% | -28.2% | ||
| Q4 24 | -24.9% | -55.6% | ||
| Q3 24 | -17.0% | -32.5% | ||
| Q2 24 | -62.2% | — | ||
| Q1 24 | -36.3% | — |
净利率FORALSH
| Q4 25 | -22.9% | -22.6% | ||
| Q3 25 | -1.9% | -22.2% | ||
| Q2 25 | 3.0% | -14.2% | ||
| Q1 25 | -16.0% | -28.2% | ||
| Q4 24 | 3.4% | -54.1% | ||
| Q3 24 | -4.4% | -32.7% | ||
| Q2 24 | -53.4% | — | ||
| Q1 24 | -24.9% | — |
每股收益（稀释后）FORALSH
| Q4 25 | $-0.06 | $-0.08 | ||
| Q3 25 | $0.00 | $-0.09 | ||
| Q2 25 | $0.01 | $-0.11 | ||
| Q1 25 | $-0.04 | $-0.14 | ||
| Q4 24 | $0.01 | $-0.26 | ||
| Q3 24 | $-0.01 | $-0.18 | ||
| Q2 24 | $-0.08 | — | ||
| Q1 24 | $-0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.6M | $1.6M |
| 总债务越低越好 | — | $2.4M |
| 股东权益账面价值 | $29.8M | $12.2M |
| 总资产 | $44.1M | $24.3M |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资FORALSH
| Q4 25 | $31.6M | $1.6M | ||
| Q3 25 | $28.2M | $4.5M | ||
| Q2 25 | $35.6M | $5.0M | ||
| Q1 25 | $35.7M | $1.5M | ||
| Q4 24 | $35.1M | $1.1M | ||
| Q3 24 | $49.4M | $2.7M | ||
| Q2 24 | $48.0M | — | ||
| Q1 24 | $47.4M | — |
总债务FORALSH
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $2.4M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $774.2K | ||
| Q4 24 | — | $784.8K | ||
| Q3 24 | — | $589.9K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FORALSH
| Q4 25 | $29.8M | $12.2M | ||
| Q3 25 | $31.1M | $7.0M | ||
| Q2 25 | $30.9M | $2.8M | ||
| Q1 25 | $30.0M | $749.8K | ||
| Q4 24 | $30.1M | $1.6M | ||
| Q3 24 | $28.4M | $3.6M | ||
| Q2 24 | $27.2M | — | ||
| Q1 24 | $28.1M | — |
总资产FORALSH
| Q4 25 | $44.1M | $24.3M | ||
| Q3 25 | $41.3M | $18.6M | ||
| Q2 25 | $48.5M | $14.4M | ||
| Q1 25 | $48.6M | $9.9M | ||
| Q4 24 | $47.2M | $9.8M | ||
| Q3 24 | $57.5M | $10.8M | ||
| Q2 24 | $58.4M | — | ||
| Q1 24 | $57.5M | — |
负债/权益比FORALSH
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 0.48× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-453.5K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FORALSH
| Q4 25 | $3.2M | $-453.5K | ||
| Q3 25 | $-439.7K | $-4.0M | ||
| Q2 25 | $-344.5K | $-483.7K | ||
| Q1 25 | $448.2K | $-238.3K | ||
| Q4 24 | $1.7M | $-530.2K | ||
| Q3 24 | $764.1K | $-1.4M | ||
| Q2 24 | $-23.1K | — | ||
| Q1 24 | $-2.2M | — |
自由现金流FORALSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-497.4K | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-560.5K | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率FORALSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -7.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.6% | ||
| Q3 24 | — | -34.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度FORALSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率FORALSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.53× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 8.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
